ASH Daily News 5 February 2018
- Plans for NHS e-cigarette prescriptions stall after BAT abandons the only device licensed for medical use
- Scotland: BMA warns that Brexit could pose substantial public health risks
- 92% of smokers in Greater Manchester underestimate the risks
- Isle of Man: E-cigarette trial period sees improved behaviour in prisons
- New laboratory study into e-cigarettes shows some flavours have greater impact on cells than others
- USA: New Jersey could be the first state to ban menthol cigarettes
Plans for NHS e-cigarette prescriptions stall after BAT abandons the only device licensed for medical use
Plans for prescribing e-cigarettes on the NHS have stalled after British American Tobacco (BAT) said that their medicinally licensed product is now facing production difficulties.
The eVoke device received approval for medical use two years ago, with the hope that it could help thousands of smokers to quit.
Since that time, BAT has insisted that it would be able to make a non-commercial product complying with regulations on particles and nicotine that are required for a prescription product, but that scaling up the manufacturing process had caused technical problems. BAT said that rapid developments in the technology for e-cigarettes had left the eVoke out of date.
Professor Linda Bauld, who lectures on health policy at Stirling University, said: “I am disappointed not to see at least one type of electronic cigarette available on the NHS to help people quit smoking and which is significantly safer than cigarettes, available for a small prescription charge”.
Source: The Daily Mail, 5 February 2018
Scotland: BMA warns that Brexit could pose substantial public health risks
British Medical Association (BMA) Scotland has raised concerns that new trade deals struck by the UK after leaving the EU could make it easier for companies to challenge ‘legitimate measures to improve public health’.
BMA Scotland chair Dr Peter Bennie said: “The BMA have been clear that Brexit poses a series of substantial risks to healthcare and public health in Scotland. We are yet to see sufficient action to believe there is a real commitment to address these issues”.
He added: “There must be a clear red line which rules out any moves that put at risk the ability of governments to introduce legitimate measures that tackle the extremely serious public health issues we face.
There is a risk that new trade deals may increase the power of business and investors to challenge or even demand compensation when legitimate measures to improve public health are introduced”.
He made the comments as the BMA outlined its concerns about the impact of Brexit on public health in a submission to MSPs.
Source: The Daily Mail, 2 February 2018
92% of smokers in Greater Manchester underestimate the risks
The ‘Don’t be The 1’ campaign to help smokers quit is being rolled out on TV and across social media in Greater Manchester, highlighting the effects of addiction on smokers and their families.
New figures released today show that hundreds of thousands of smokers in Greater Manchester are under-estimating the risks of their addiction, with a survey finding that 92% of smokers are unaware that tobacco accounts for 1 in 2 deaths among smokers.
‘Don’t Be The 1’ is the first campaign of its kind to run in Greater Manchester, having previously been rolled out across the North East. It is part of a wider campaign towards a tobacco-free Greater Manchester called ‘Making Smoking History’ that will run in 2018.
Source: Key 103, 5 February 2018
Isle of Man: E-cigarette trial period sees improved behaviour in prisons
A trial period for the use of e-cigarettes at the Isle of Man Prison has led to improved behaviour and more prisoners seeking stop smoking support.
The Prison and Probation Service and Public Health Directorate ran a six-month trial last year, allowing prisoners to use e-cigarettes instead of solely being able to use nicotine replacement patches.
The prison at Jurby, which was the first in Europe to ban smoking in 2008, saw a 58% drop in behaviour warnings and a 42% fall in offender adjudications during the period.
Source: Energy FM, 3 February 2018
New laboratory study into e-cigarettes shows some flavours have greater impact on cells than others
Researchers at the University of Rochester Medical Center in New York have conducted a study into the effects of nicotine-free vaping.
They found that some chemicals used to create e-liquid flavours can cause inflammation and tissue damage in two types of white blood cell.
The research also showed that some flavour brands had a greater effect than others.
Source: Medical News Today, 5 February 2018
USA: New Jersey could be the first state to ban menthol cigarettes
New Jersey could become the first US state to outlaw the sale of menthol cigarettes.
Legislation banning the cigarettes was approved on Monday 29 January by the New Jersey Assembly Health and Senior Services Committee and will now be given further consideration. Similar legislation has not yet been introduced in the state senate.
The measure would amend existing state law by adding menthol-flavored cigarettes to the state’s list of prohibited flavored cigarettes.
Marc Kaplan, a spokesman for the American Cancer Society, stated: “We support efforts to reduce tobacco use and the availability of deadly tobacco products, as tobacco use remains the leading cause of preventable death”.
Source: The Daily Mail, 4 February 2018